Business Wire

Corona Spearheads Eco-Tourism with Corona Island, the World’s First Blue Verified, Single-Use Plastic-Free Island

Share

Today, global beer brand Corona announces the grand opening of Corona Island, a tropical sustainable destination for eco-tourism off the coast of Colombia. A first-of-its-kind island paradise, Corona Island is free of single-use plastic, encouraging guests to reconnect with the natural world through immersive hospitality experiences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220809005308/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Corona Island (Photo: Business Wire)

As a beer made with natural ingredients that was born at the beach and the first global beverage brand with a net-zero plastic footprint*, Corona partnered with international nonprofit Oceanic Global to create the first Blue Verified island.

Corona Island has achieved Oceanic Global’s three-star plastic-free Blue Seal for eliminating single-use plastic and adopting sustainable operating best practices at scale. From construction to energy production, food sourcing and guest experiences on-site, sustainability is at the center of every decision and touchpoint of Corona Island.

“On Corona Island, we are celebrating the majesty and beauty of the outdoors by getting guests engaged in protecting paradise,” said Felipe Ambra, Global Vice President for Corona. “Everyone on the team, from our chefs to our architects contributed to creating a truly single-use plastic-free paradise. We look forward to welcoming visitors, rekindling their relationship with nature and hopefully creating more advocates to protect our natural world.”

“Oceanic Global is honored to help develop the Corona Island experience and applauds Corona’s sector-leading sustainability efforts,” said Lea d’Auriol, Founder and Executive Director at Oceanic Global. “We’re proud to have worked with Corona from the beginning of the project to ensure that this sustainable destination demonstrates how travelers can experience paradise for both leisure and educational purposes, while leaving a minimal trace behind.”

Exclusive island features:

  • Design and vision for the island led by international architectural and design firm, James & Mau, in partnership with local Colombian architect, Jairo Márquez.
  • Guest menus created by Chilean-born Chef Christopher Carpentier, who was featured as a judge on MasterChef Colombia.
  • Corona Island’s leisure programs are curated by Paulina Vega, former Miss Universe, who was born on the Colombian coast.
  • Educational workshops and excursions hosted as part of Oceanic Global’s “Blue School”.

For more details, and to learn how to book a stay on Corona Island starting Summer 2023,** please visit the registration page here.

*AB InBev's 2021 Environmental, Social & Governance. Report. Retrieved from https://www.ab-inbev.com/assets/pdfs/ABINBEV_ESG_2021_Final.pdf - page 37.

**U.S. Residents are not eligible for purchasing stays on Corona Island. Corona and some of the Modelo beer brands have been licensed to a third party for the U.S. territory.

About Corona Global

Born in Mexico, Corona is the leading beer brand in the country, the most popular Mexican beer worldwide exported to more than 180 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City. Corona is a pioneer in the beer industry by being the first to use a transparent bottle showcasing its purity and high quality to the world. The artwork found on the bottle is painted, highlighting our commitment to quality in our packaging and our Mexican heritage. No Corona is complete without the lime. Naturally adding character, flavor and refreshment, the lime ritual is an integral part of delivering an experience that is truly unique to Corona. The brand is synonymous with the beach and celebrates time outdoors. It invites people to pause, relax and enjoy the simple pleasures of life.

Corona has an ongoing commitment to reducing plastics. Since its partnership with Parley for the Oceans in 2017, they have exceeded its mission to protect 100 islands before 2020, and continue to deploy consistent global clean-up efforts.

About Anheuser-Busch InBev

Anheuser-Busch InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona® and Stella Artois®; multi-country brands Beck’s®, Hoegaarden®, Leffe® and Michelob ULTRA®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 169,000 colleagues based in nearly 50 countries worldwide. For 2021, AB InBev’s reported revenue was 54.3 billion USD (excluding JVs and associates).

About Oceanic Global

Founded in 2016 by Lea d’Auriol, Oceanic Global (OG) inspires us to care deeply for the ocean and provides solutions to protect it. The international non-profit sheds light on humanity’s essential relationship to the ocean and empowers individuals, communities, and industries to create positive change. Oceanic Global creates educational experiences, consults on sustainable operations, and engages local communities to generate measurable impact for our collective wellbeing. In 2020, Oceanic Global launched the Blue Standard (Blue), a first-of-its-kind cross industry standard that establishes universal accountability for sustainable business leadership and empowers industries and businesses of all sizes to achieve measurable impact that protects our blue planet. Oceanic Global is based in Brooklyn, New York with international hubs & volunteer bases in New York, London, Los Angeles, Barcelona, Tulum, and Hong Kong. Reflective of its global reach, the organization has additionally produced United Nations World Oceans Day since 2019. #CareDeeply | www.oceanic.global

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
AB InBev Media Relations
E-mail: media.relations@ab-inbev.com

Faith Yi
Tel: +1 206.226.0859
E-mail: coronaglobal@allisonpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release

IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye